BEAM

10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential

06/28 09:10 am

Editas Medicine Is Great. Here's Why You Shouldn't Buy It.

06/17 10:07 am

Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

05/29 04:01 pm

Why Beam Therapeutics Stock Tanked on Tuesday

05/06 05:05 pm

Beam Therapeutics Announces Pricing of Underwritten Offering

03/10 06:01 am

Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences

02/24 08:00 am

Beam Therapeutics to Participate in Guggenheim SMID Cap Biotech Conference

01/30 08:00 am

Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight

12/19 02:00 pm

Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for ESCAPE, a Non-genotoxic, Antibody-based Conditioning Approach to Treating Sickle Cell Disease, at American Society of Hematology (ASH) Annual Meeting

12/08 02:45 pm

Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

12/07 12:30 pm

Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer

12/06 08:00 am

Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?

11/24 06:47 am

Gene Editing Therapeutics Market Forecast 2024-2029: A $1 Billion Market by 2029, with a Forecasted CAGR of 147%

09/10 04:51 am

Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast - Benzinga

07/18 10:12 pm

Beam Therapeutics Announces Transition of Chief Financial Officer - GlobeNewswire

07/15 06:32 am

Here's Why You Should Invest in Beam Therapeutics (BEAM) Now - Zacks Investment Research

07/11 12:01 pm

Beam Therapeutics (BEAM) Begins Dosing in Phase I/II AATD Study

06/27 10:26 am

Beam Therapeutics Announces First Patient Dosed in the Phase 1/2 Study of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD)

06/26 06:30 am

Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease

06/14 03:00 am

Why Is Beam Therapeutics (BEAM) Up 10.1% Since Last Earnings Report?

06/06 11:31 am

Beam Therapeutics to Participate in Jefferies Global Healthcare Conference

05/30 06:30 am

Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss

05/08 10:52 am

Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference

05/08 06:30 am

Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results

05/07 06:30 am

Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates

05/02 05:10 pm

Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

05/01 10:01 am

Expert Ratings For Beam Therapeutics

04/23 02:00 pm

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2024 Update

04/19 03:54 am

Why Is Beam Therapeutics (BEAM) Down 22.1% Since Last Earnings Report?

03/28 11:30 am

Expert Outlook: Beam Therapeutics Through The Eyes Of 4 Analysts

03/27 11:01 am

Beam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

03/26 06:30 am

Navigating 4 Analyst Ratings For Beam Therapeutics

02/28 11:00 am

Beam Therapeutics to Participate in Upcoming March 2024 Investor Conferences

02/28 07:30 am

Brian's Big Idea on Healthcare

02/27 04:39 pm

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

02/27 02:18 pm

Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday

02/27 11:27 am

Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones

02/27 07:30 am

Harmony Biosciences Holdings, Inc. (HRMY) Misses Q4 Earnings and Revenue Estimates

02/22 09:45 am

Earnings Preview: Beam Therapeutics Inc. (BEAM) Q4 Earnings Expected to Decline

02/20 11:00 am

5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates

02/15 06:45 am

Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss

02/09 12:49 am

Beam Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

02/05 07:30 am

Why Beam Therapeutics Stock Zoomed 17% Higher Today

01/29 07:21 pm

3 Incredible Growth Stocks That Could Soar in 2024, According to Wall Street

01/16 10:00 am

Beam Therapeutics Highlights Progress Across Base Editing Portfolio and Outlines 2024 Anticipated Milestones

01/08 07:30 am

4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024

01/08 06:52 am

BEAM Stock Rallies More Than 25% in 3 Months: What Next?

01/03 11:52 am

Beam Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

01/02 07:30 am

2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street

12/27 11:30 am

The Zacks Analyst Blog Highlights bluebird, Editas Medicine, Beam Therapeutics and Intellia Therapeutics

12/14 11:36 am